文献速递帕金森病与运动障碍

亚洲人群帕金森病风险位点识别及与欧洲人群风险比较:全基因组关联研究

Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.
PubMed 文献 · JAMA Neurol · 2020-01-01

该研究在亚洲人群中开展全基因组关联分析,发现11个帕金森病显著关联位点,其中SV2C和WBSCR17为新位点,9个为欧洲人群已知位点。SV2C在欧洲和日本样本中重复验证,WBSCR17存在遗传异质性。包含11个位点的多基因风险评分较仅用78个欧洲位点模型显著提高曲线下面积(63.1% vs 60.2%,P=6.81×10^-12)。

要点

  • 亚洲人群发现11个帕金森病显著位点,其中SV2C和WBSCR17为新位点。
  • SV2C在跨种族重复中稳健关联(OR=1.16,95%CI 1.11-1.21,P=1.17×10^-10)。
  • 包含11个位点的多基因风险评分提高预测效能(AUC 63.1% vs 60.2%)。

核心结论

  • 在亚洲人群中识别出2个新的帕金森病风险位点(SV2C和WBSCR17)及9个欧洲已知位点。
  • 亚洲与欧洲人群帕金森病遗传风险因素存在相似性和差异。
  • 多基因风险评分可能改善亚洲人群风险分层和精准医学应用。

研究设计与样本

  • 帕金森病诊断采用英国帕金森病学会脑库标准。
  • 采用逆方差meta分析合并结果,并对顶级位点在欧洲和日本样本中进行重复验证。
  • 发现阶段采集时间为2016年1月1日至2018年12月31日。

主要发现

  • 发现阶段识别11个全基因组显著位点:2个新位点(SV2C和WBSCR17)和9个欧洲已知位点。
  • SV2C(rs246814)在发现与重复样本meta分析中稳健关联:OR=1.16,95%CI 1.11-1.21,P=1.17×10^-10。
  • WBSCR17(rs9638616)显示潜在遗传异质性:I²=67.1%,异质性P=3.40×10^-3。
  • 包含11个位点的多基因风险评分模型AUC为63.1%,优于仅基于78个欧洲位点模型的60.2%(P=6.81×10^-12)。

关键数值与推荐

  • 全基因组显著位点共11个,其中新位点2个,已知欧洲位点9个。
  • 多基因风险评分AUC:63.1%(11位点模型) vs 60.2%(78欧洲位点模型),P=6.81×10^-12。

临床怎么用

  • 研究结果支持在亚洲人群中应用多基因风险评分进行帕金森病风险分层。
  • SV2C位点可能作为跨种族稳健的风险标记。
  • WBSCR17的异质性提示需谨慎解读该位点在跨种族中的应用。

局限性

  • WBSCR17位点存在显著异质性(I²=67.1%),限制其跨种族推广。
  • 研究未报告其他临床或功能验证结果。
  • 重复队列以欧洲血统为主,日本样本量相对较小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian). OBJECTIVES: To identify novel genome-wide significant loci for PD in Asian individuals and to compare genetic risk between Asian and European cohorts. DESIGN SETTING, AND PARTICIPANTS: Genome-wide association data generated from PD cases and controls in an Asian population (ie, Singapore/Malaysia, Hong Kong, Taiwan, mainland China, and South Korea) were collected from January 1, 2016, to December 31, 2018, as part of an ongoing study. Results were combined with inverse variance meta-analysis, and replication of top loci in European and Japanese samples was performed. Discovery samples of 31 575 individuals passing quality control of 35 994 recruited were used, with a greater than 90% participation rate. A replication cohort of 1 926 361 European-ancestry and 3509 Japanese samples was analyzed. Parkinson disease was diagnosed using UK Parkinson's Disease Society Brain Bank Criteria. MAIN OUTCOMES AND MEASURES: Genotypes of common variants, association with disease status, and polygenic risk scores. RESULTS: Of 31 575 samples identified, 6724 PD cases (mean [SD] age, 64.3 [10] years; age at onset, 58.8 [10.6] years; 3472 [53.2%] men) and 24 851 controls (age, 59.4 [11.4] years; 11 030 [45.0%] men) were analyzed in the discovery study. Eleven genome-wide significant loci were identified; 2 of these loci were novel (SV2C and WBSCR17) and 9 were previously found in Europeans. Replication in European-ancestry and Japanese samples showed robust association for SV2C (rs246814; odds ratio, 1.16; 95% CI, 1.11-1.21; P = 1.17 × 10-10 in meta-analysis of discovery and replication samples) but showed potential genetic heterogeneity at WBSCR17 (rs9638616; I2=67.1%; P = 3.40 × 10-3 for hetereogeneity). Polygenic risk score models including variants at these 11 loci were associated with a significant improvement in area under the curve over the model based on 78 European loci alone (63.1% vs 60.2%; P = 6.81 × 10-12). CONCLUSIONS AND RELEVANCE: This study identified 2 apparently novel gene loci and found 9 previously identified European loci to be associated with PD in this large, meta-genome-wide association study in a worldwide population of Asian individuals and reports similarities and differences in genetic risk factors between Asian and European individuals in the risk for PD. These findings may lead to improved stratification of Asian patients and controls based on polygenic risk scores. Our findings have potential academic and clinical importance for risk stratification and precision medicine in Asia.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Foo JN, Chew EGY, Chung SJ, et al. Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study. JAMA Neurol. 2020. PMID: 32310270. doi:10.1001/jamaneurol.2020.0428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。